RISK SCORES BASED ON HUMAN PHOSPHODIESTERASE 4 D VARIANT 7 EXPRESSION

摘要

Methods are described for stratifying patient risk for patients with prostate cancer and for providing a treatment recommendation to a patient based on a phosphodiesterase 4D variant 7 (PDE4D7) risk score. A diagnostic kit and a computer program product for the analysis and determination of the PDE4D7 risk score are also described.